Market Research Future (MRFR) has announced a new release on the Global Circulating Tumor Cell Market. The report presents a detailed analysis of the market’s likely growth trajectory and drivers over the forecast period from 2018 to 2023, based on a solid examination of the market’s growth over the past few years. According to the report, the global circulating tumor cells market was valued at USD 9,393.1 mn in 2017 and is expected to rise to a valuation of USD 28,300 mn by the end of 2023.
Circulating tumor cells (CTC) are cancerous cells that break off from the original site of the cancer and spread throughout the body through the vascular system. These cells thus act as the “seed” for cancer metastases. The highly adverse prognosis for cancer with metastasis has resulted in an increasing interest in circulating tumor cells, as they can act as an early warning system for cancer metastasis. The clinical significance of circulating tumor cells was first recognized in 1869, but serious medical research within the context of the modern structure of the healthcare sector began in the 1990s. These studies were inspired by calculations that showed that even small cancerous growths shedding cells at a small rate of less than 1% per day would produce enough circulating tumor cells in the bloodstream to be detectable.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1362
The growing prevalence of cancer is likely to be the major driver for the global circulating tumor cell market over the forecast period. Over 90% of the deaths caused by cancer are caused by cancers that have metastasized, leading to the field of circulating tumor cells taking on a highly important position in modern oncology. Circulating tumor cells can thus be used as an early warning of progressive cancer; the growing clamor for advances in cancer prevention rather than treatment is expected to drive the circulating tumor cells market over the forecast period. Circulating tumor cells also provide the perfect way to monitor the development of a cancer in an individual, as simple blood tests can be used in place of invasive biopsies to measure the prevalence of CTCs as the disease progresses.
Global Circulating Tumor Cell Market – Competitive Analysis
Leading players in the global circulating tumor cells market include Ikonisys Inc., Thermo Fisher Scientific, STEMCELL Technologies, Menarini Silicon Biosystems, F. Hoffman-La Roche Ltd., Fluxion Biosciences Inc., ApoCell, Epic Lifesciences, Celltraffix Inc., Advanced Cell Diagnostics Inc. (Bio-Techne Corporation), GE Healthcare, NanoString Technologies Inc., QIAGEN, Miltenyi Biotec, SRI International, and Greiner Bio-One International GmbH.
In May 2018, CellMax launched a new clinical trial in an effort to validate its CTC screening test for colorectal cancer in the U.S.
Global Circulating Tumor Cell Market – Segmentation
The Global Circulating Tumor Cells Market is segmented by technology, application, end use, and region in the report.
The global circulating tumor cell market is segmented on the basis of technology into CTC enrichment, CTC detection, and combined enrichment and separation of CTC.
On the basis of application, the global circulating tumor cell market is segmented into clinical, research, and drug development.
By end use, the CTC market is segmented into hospitals & clinics, research & academic institutes, and diagnostic centers.
Global Circulating Tumor Cell Market – Regional Analysis
The Global Circulating Tumor Cells Market is segmented on the basis of region into North America, South America, Europe, Asia Pacific, and the Middle East and Africa.
North America is likely to be the dominant regional market for circulating tumor cell research and technology over the forecast period. The highly advanced state of the healthcare sector in North America is a major factor conducive for steady growth of the circulating tumor cell market in the region. The growing prevalence of cancer in North America and the increasing efforts to update and enhance the means to combat the same are likely to result in a steady growth in demand from the circulating tumor cell market in the region.
Browse Complete 110 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/circulating-tumor-cell-market-1362
Asia Pacific is also expected to exhibit steady growth in the global circulating tumor cells market over the forecast period due to the increasing healthcare expenditure in emerging countries in the region and the increasing prevalence of cancer.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune – 411028
+1 646 845 9312